J. Goldman & Co LP - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is and the CUSIP is 88338N206. A total of 45 filers reported holding THERAPEUTICSMD INC in Q3 2022. The put-call ratio across all filers is 2.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q3 2023$40,957
-26.7%
13,5620.0%0.00%
-50.0%
Q2 2023$55,875
+9.9%
13,5620.0%0.00%0.0%
Q1 2023$50,858
-32.9%
13,5620.0%0.00%
-50.0%
Q4 2022$75,812
-86.2%
13,562
-83.7%
0.00%
-84.6%
Q3 2022$551,00082,9760.03%
Other shareholders
THERAPEUTICSMD INC shareholders Q3 2022
NameSharesValueWeighting ↓
Rubric Capital Management LP 791,831$7,879,0000.41%
PenderFund Capital Management Ltd. 24,410$313,0000.09%
EQUITEC PROPRIETARY MARKETS, LLC 16,500$164,0000.05%
EQUITEC PROPRIETARY MARKETS, LLC 12,600$125,0000.04%
Asset Management Group, Inc. 14,701$146,0000.04%
EQUITEC PROPRIETARY MARKETS, LLC 11,455$114,0000.03%
Ergoteles LLC 84,700$843,0000.02%
XR Securities LLC 41,200$66,0000.02%
State of Wyoming 2,932$29,0000.02%
CSS LLC/IL 21,782$217,0000.01%
View complete list of THERAPEUTICSMD INC shareholders